Arvinas is a biotechnology company that develops drugs to treat cancer and other diseases. The company's technology uses small molecules to target and degrade disease-causing proteins, which can be more effective than traditional approaches that target proteins directly. Arvinas has partnerships with several pharmaceutical companies to develop drugs using its technology, and has several drug candidates in clinical trials.